Chris Shelley

2.1k total citations · 1 hit paper
39 papers, 1.7k citations indexed

About

Chris Shelley is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Immunology and Allergy. According to data from OpenAlex, Chris Shelley has authored 39 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 11 papers in Cellular and Molecular Neuroscience and 11 papers in Immunology and Allergy. Recurrent topics in Chris Shelley's work include Ion channel regulation and function (11 papers), Cell Adhesion Molecules Research (11 papers) and Neuroscience and Neuropharmacology Research (6 papers). Chris Shelley is often cited by papers focused on Ion channel regulation and function (11 papers), Cell Adhesion Molecules Research (11 papers) and Neuroscience and Neuropharmacology Research (6 papers). Chris Shelley collaborates with scholars based in United States, United Kingdom and France. Chris Shelley's co-authors include M. Amin Arnaout, Omid C. Farokhzad, Francisco E. Baralle, Ailsa Webster, Mike Hutton, Bryan John Smith, Michael J. Butler, Andrew Docherty, Gillian Murphy and Vera Knäuper and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Neuroscience.

In The Last Decade

Chris Shelley

39 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

TNF‐α converting enzyme (TACE) is inhibited by TIMP‐3

1998 519 citations Augustin Amour, Patrick M. Slocombe et al. FEBS Letters profile →

Peers

Chris Shelley

IMMUN

CMN

Steven Swendeman United States

Joseph P. Gardner United States

Anika Agarwal United States

Edward Monosov United States

Jörg Klingelhöfer Denmark

Denis Banville Canada

Reinhard Wetzker Germany

Sheila Harroch France

Stefan Wennström Sweden

Patrick Auguste France

Steven Swendeman United States

Chris Shelley

1.7k ×1.7

267 ×0.7

241 ×0.7

508 ×1.6

IMMUN

149 ×0.5

CMN

Citations per year, relative to Chris Shelley Chris Shelley (= 1×) peers Steven Swendeman

Countries citing papers authored by Chris Shelley

Since Specialization

Citations

This map shows the geographic impact of Chris Shelley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris Shelley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris Shelley more than expected).

Fields of papers citing papers by Chris Shelley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chris Shelley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris Shelley. The network helps show where Chris Shelley may publish in the future.

Co-authorship network of co-authors of Chris Shelley

This figure shows the co-authorship network connecting the top 25 collaborators of Chris Shelley. A scholar is included among the top collaborators of Chris Shelley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chris Shelley. Chris Shelley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shelley, Chris, et al.. (2023). The dopamine receptor antagonist haloperidol disrupts behavioral responses of sea urchins and sea stars. Journal of Experimental Biology. 226(17). 1 indexed citations

Perszyk, Riley E., Sharon A. Swanger, Chris Shelley, et al.. (2020). Biased modulators of NMDA receptors control channel opening and ion selectivity. Nature Chemical Biology. 16(2). 188–196. 27 indexed citations

Coombs, Ian D., et al.. (2017). Multiple Subconductance States of Tarped AMPA Receptors Revealed by Slow Dissociation of Antagonist. Biophysical Journal. 112(3). 418a–418a. 1 indexed citations

Coombs, Ian D., David Soto, Marzieh Zonouzi, et al.. (2012). Cornichons Modify Channel Properties of Recombinant and Glial AMPA Receptors. Journal of Neuroscience. 32(29). 9796–9804. 77 indexed citations

Shelley, Chris, Mark Farrant, & Stuart Cull-Candy. (2012). TARP‐associated AMPA receptors display an increased maximum channel conductance and multiple kinetically distinct open states. The Journal of Physiology. 590(22). 5723–5738. 37 indexed citations

Shelley, Chris & David Colquhoun. (2008). A human congenital myasthenia-causing-mutation (epsilon L78P) of the muscle nicotinic acetylcholine receptor with unusual single channel properties (vol 564, pg 377, 2005). The Journal of Physiology. 1 indexed citations

Shelley, Chris & David Colquhoun. (2005). A human congenital myasthenia‐causing mutation (ɛL78P) of the muscle nicotinic acetylcholine receptor with unusual single channel properties. The Journal of Physiology. 564(2). 377–396. 8 indexed citations

Hatton, C. J., Chris Shelley, M Brydson, David Beeson, & David Colquhoun. (2003). Properties of the human muscle nicotinic receptor, and of the slow-channel myasthenic syndrome mutant L221F, inferred from maximum likelihood fits. The Journal of Physiology. 547(3). 729–760. 62 indexed citations

Nicolaou, Fotini, Jens M. Teodoridis, Heiyoung Park, et al.. (2003). CD11c gene expression in hairy cell leukemia is dependent upon activation of the proto-oncogenes ras andjunD. Blood. 101(10). 4033–4041. 35 indexed citations

10.

Beeson, David, Richard Webster, John Ealing, et al.. (2003). Structural Abnormalities of the AChR Caused by Mutations Underlying Congenital Myasthenic Syndromes. Annals of the New York Academy of Sciences. 998(1). 114–124. 9 indexed citations

11.

Croxen, R, C. J. Hatton, Chris Shelley, et al.. (2002). Recessive inheritance and variable pentrance of slow channel myasthenic syndromes. Journal of Neurology Neurosurgery & Psychiatry. 73. 229–229. 2 indexed citations

12.

Shelley, Chris, Jens M. Teodoridis, Heiyoung Park, et al.. (2002). During Differentiation of the Monocytic Cell Line U937, Purα Mediates Induction of the CD11c β2 Integrin Gene Promoter. The Journal of Immunology. 168(8). 3887–3893. 41 indexed citations

13.

Shelley, Chris, Nicolas Da Silva, & Jens M. Teodoridis. (2001). During U937 monocytic differentiation repression of the CD43 gene promoter is mediated by the single‐stranded DNA binding protein Purα. British Journal of Haematology. 115(1). 159–166. 24 indexed citations

14.

Shelley, Chris, et al.. (1998). Mapping of the Human CD11c (ITGAX) and CD11d (ITGAD) Genes Demonstrates That They Are Arranged in Tandem Separated by No More Than 11.5 kb. Genomics. 49(2). 334–336. 7 indexed citations

15.

Amour, Augustin, Patrick M. Slocombe, Ailsa Webster, et al.. (1998). TNF‐α converting enzyme (TACE) is inhibited by TIMP‐3. FEBS Letters. 435(1). 39–44. 519 indexed citations breakdown →

16.

Farokhzad, Omid C., Chris Shelley, & M. Amin Arnaout. (1996). Induction of the CD11b gene during activation of the monocytic cell line U937 requires a novel nuclear factor MS-2. The Journal of Immunology. 157(12). 5597–5605. 21 indexed citations

17.

Böttinger, Erwin P., Chris Shelley, Omid C. Farokhzad, & M. Amin Arnaout. (1994). The Human β2 Integrin CD18 promoter consists of Two Inverted Ets cis Elements. Molecular and Cellular Biology. 14(4). 2604–2615. 10 indexed citations

18.

Shelley, Chris, Eileen Remold‐O’Donnell, Alvin E. Davis, et al.. (1989). Molecular characterization of sialophorin (CD43), the lymphocyte surface sialoglycoprotein defective in Wiskott-Aldrich syndrome.. Proceedings of the National Academy of Sciences. 86(8). 2819–2823. 121 indexed citations

19.

Shelley, Chris & Francisco E. Baralle. (1987). Deletion analysis of a unique 3' splice site indicates that alternating guanine and thymine residues represent an efficient splicing signal. Nucleic Acids Research. 15(9). 3787–3799. 20 indexed citations

20.

Shelley, Chris & Francisco E. Baralle. (1987). Dual tissue-specific expression of apo-AII is directed by an upstream enhancer. Nucleic Acids Research. 15(9). 3801–3821. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact